References
1. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 2011;377(9773):1264-1275.
2. Singleton RJ, Holman RC, Folkema AM, Wenger JD, Steiner CA, Redd JT. Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population. J Pediatr 2012;161(2).
3. Hasegawa K, Tsugawa Y, Brown DFM, Mansbach JM, Camargo CA. Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics 2013;132(1):28-36.
4. Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet 2017;389(10065):211-224.
5. Asner SA, Science ME, Tran D, Smieja M, Merglen A, Mertz D. Clinical disease severity of respiratory viral coinfection versus single viral infection: A systematic review and meta-analysis. PLoS One 2014;9(6).
6. Richard N, Komurian-Pradel F, Javouhey E, Perret M, Rajoharison A, Bagnaud A, Billaud G, Vernet G, Lina B, Floret D, et al. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J 2008;27(3):213-217.
7. Brand HK, De Groot R, Galama JMD, Brouwer ML, Teuwen K, Hermans PWM, Melchers WJG, Warris A. Infection with multiple viruses is not associated with increased disease severity in children with bronchiolitis. Pediatr Pulmonol 2012;47(4):393-400.
8. Eşki A, Öztürk GK, Gülen F, Çiçek C, Demir E. Risk factors for infuenza virus related severe lower respiratory tract infection in children. Pediatr Infect Dis J 2019;38(11):1090-1095.
9. Scotta MC, Chakr VCBG, de Moura A, Becker RG, de Souza APD, Jones MH, Pinto LA, Sarria EE, Pitrez PM, Stein RT, et al. Respiratory viral coinfection and disease severity in children: A systematic review and meta-analysis. J Clin Virol 2016;80:45-56.
10. Goka EA, Vallely PJ, Mutton KJ, Klapper PE. Single and multiple respiratory virus infections and severity of respiratory disease: A systematic review. Paediatr Respir Rev 2014;15(4):363-370.
11. WHO. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. 2013.
12. Raymond J, Aujard Y. Nosocomial Infections in Pediatric Patients A European, Multicenter Prospective Study. Infect Control 2000;21(4):260-263.
13. Asner SA, Rose W, Petrich A, Richardson S, Tran DJ. Is virus coinfection a predictor of severity in children with viral respiratory infections? Clin Microbiol Infect 2015;21(3):264.e1-264.e6.
14. Jackson S, Mathews KH, Pulanić D, Falconer R, Rudan I, Campbell H, Nair H. Risk factors for severe acute lower respiratory infections in children - a systematic review and meta-analysis. Croat Med J 2013;54(2):110-121.
15. Sonego M, Pellegrin MC, Becker G, Lazzerini M. Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: A systematic review and meta-analysis of observational studies. PLoS One 2015;10(1).
16. Mazur NI, Bont L, Cohen AL, Cohen C, Von Gottberg A, Groome MJ, Hellferscee O, Klipstein-Grobusch K, Mekgoe O, Naby F, et al. severity of respiratory syncytial virus lower respiratory tract infection with viral coinfection in HIV-uninfected children. Clin Infect Dis 2017;64(4):443-450.
17. Statement P. Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. 2017.
18. Das MK, Bhattacharyya N, Bhattacharyya AK. WHO child growth standards. 2010.
19. Lanzkowsky’s Manual of Pediatric Hematology and Oncology. 2016.
20. Cangiano G, Nenna R, Frassanito A, Evangelisti M, Nicolai A, Scagnolari C, Pierangeli A, Antonelli G, Papoff P, Petrarca L, et al. Bronchiolitis: Analysis of 10 consecutive epidemic seasons. Pediatr Pulmonol 2016;51(12):1330-1335.
21. Martínez-Roig A, Salvadó M, Caballero-Rabasco MA, Sánchez-Buenavida A, López-Segura N, Bonet-Alcaina M. Viral Coinfection in Childhood Respiratory Tract Infections. Arch Bronconeumol 2015;51(1):5-9.
22. Harada Y, Kinoshita F, Yoshida LM, Le Nhat M, Suzuki M, Morimoto K, Toku Y, Tomimasu K, Moriuchi H, Ariyoshi K. Does respiratory virus coinfection increases the clinical severity of acute respiratory infection among children infected with respiratory syncytial virus? Pediatr Infect Dis J 2013;32(5):441-445.
23. Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, Halfhide C, Shears P, Smyth RL, Hart CA. Dual Infection of Infants by Human Metapneumovirus and Human Respiratory Syncytial Virus Is Strongly Associated with Severe Bronchiolitis. J Infect Dis 2005;191(3):382-386.
24. Hammer J, Numa A, Newth CJL. Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr Pulmonol 1997;23(3):176-183.
25. DaPalma T, Doonan BP, Trager NM, Kasman LM. A systematic approach to virus-virus interactions. Virus Res 2010;149(1):1-9.
26. McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 2014;12(4):252-262.
27. Costa LF, Oliveira Queiróz DA, Lopes Da Silveira H, Bernardino Neto M, De Paula NT, Oliveira TFMS, Tolardo AL, Yokosawa J. Human rhinovirus and disease severity in children. Pediatrics 2014;133(2).
28. Xatzipsalti M, Psarros F, Konstantinou G, Gaga M, Gourgiotis D, Saxoni-Papageorgiou P, Papadopoulos NG. Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment. Clin Exp Allergy 2008;38(3):466-472.
29. Lee WM, Lemanske RF, Evans MD, Vang F, Pappas T, Gangnon R, Jackson DJ, Gern JE. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med 2012;186(9):886-891.
30. de Souza WM, Buss LF, Candido D da S, Carrera JP, Li S, Zarebski AE, Pereira RHM, Prete CA, de Souza-Santos AA, Parag K V., et al. Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nat Hum Behav 2020;4(8):856-865.
31. Zimmermann P, Curtis N. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features. Pediatr Infect Dis J 2020:469-477.
32. Lansbury L, Lim B, Baskaran V, Lim WS. Coinfections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020;81(2):266-275.
33. Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, et al. Bacterial and viral coinfections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14. J Clin Virol 2016;80:12-19.
34. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya IJ, Mahtani KR, Nunan D, et al. Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane Database Syst Rev 2014;2014(4).
35. Uršič T, Steyer A, Kopriva S, Kalan G, Krivec U, Petrovec M. Human bocavirus as the cause of a life-threatening infection. J Clin Microbiol 2011;49(3):1179-1181.
36. Knott AM, Long CE, Hall CB. Parainfluenza viral infections in pediatric outpatients: Seasonal patterns and clinical characteristics. Pediatr Infect Dis J 1994;13(4):269-273.
37. Lee MS, Walker RE, Mendelman PM. Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials. Hum Vaccin 2005;1(1):6-11.
38. WHO. WHO report on the global tobacco epidemic. 2008 [accessed 2020 May 27]. https://www.who.int/tobacco/surveillance/policy/country_profile/tur.pdf?ua=1
39. Browne MJ. Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells. Antimicrob Agents Chemother 1981;19(5):712-715.
40. O’Donnell DR, Carrington D. Peripheral blood lymphopenia and neutrophilia in children with severe respiratory syncytial virus disease. Pediatr Pulmonol 2002;34(2):128-130.